System and method for sealing cored or perforated tissue using an inflatable balloon
An inflatable balloon catheter with RF electrodes or thermal fluid, combined with autologous blood, effectively seals and promotes clotting at cored tissue sites, addressing sealing and hemostasis challenges in lung tissue.
Patent Information
- Application Number
- KR1020227042124
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-04-30
- Filing Date
- 2021-04-29
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2041-04-29
AI Technical Summary
Existing methods fail to effectively manage and seal cored or perforated tissues, such as lung tissue, particularly in controlling bleeding and air/air leakage post-tissue removal.
A system and method involving an inflatable balloon catheter with RF electrodes or thermal fluid, combined with autologous blood or other fillers, to seal the cored site and promote hemostasis and pneumostasis by minimizing filler escape.
The system provides effective sealing and hemostasis at the cored site, preventing air leakage and promoting clotting, even in lungs with collapsing or ventilating conditions.
Smart Images

Figure 112022128495917-PCT00011_ABST
Abstract
Description
Background Technology
[0001] Tissues, such as lung tissue, may have perforated or removed portions. Tissue removal may involve surgery involving, for example, the coring and removal of tissue samples from the lungs. However, problems can arise from cored or perforated tissue. Improvements are required in the management of cored or perforated tissues, such as lung tissue. Prior art literature
[65535] Prior Art Document 1: US 2019 / 388132 A1 (Publication Date: Dec. 26, 2019) Prior Art Document 2: US 2015 / 265331 A1 (Publication Date: Sep. 24, 2015) Prior Art Document 3: US 2003 / 233099 A1 (Publication Date: Dec. 18, 2003)
[0002] This application claims the priority and benefit of U.S. Patent Application No. 63 / 017,734 filed on April 30, 2020, the entirety of which is incorporated herein by reference.
[0003] It may be desirable to remove a core of tissue from target tissue sites, including but not limited to the lungs, liver, pancreas, or gastrointestinal (GI) tract, and in this case, management of bleeding after coring may be required. The tissue core may have a shape (e.g., cylindrical) and dimensions that are pre-described (e.g., predefined) based on the coring instrument. Such a coring instrument may be used to coring tissue cores of the same or substantially the same shape in a repeatable manner. Such coring may be distinguished from other tissue removals, such as those using scissors or a scalpel, where the removed tissue does not have a predefined shape or dimensions.
[0004] Once cored, it may be desirable to seal the cored tissue. As described herein, sealing may be performed during the cored process to seal blood and / or fluid flow at the core site that may result from, for example, the cored surgery itself. Additionally, or alternatively, sealing may be performed after the tissue core and / or cored device have been removed. Furthermore, sealing may occur at least once during the cored process and at least once after the tissue core and / or cored device have been removed. As an example, the cored site may be sealed during the cored process to restrict unwanted blood or flow from entering the cored site. Subsequently, the cored site may be sealed after the tissue core has been removed to restrict unwanted air from escaping through the cored site, such as in the lungs. Various sealing procedures may be utilized.
[0005] A system and / or method for sealing tissue is described herein. A method for sealing tissue at a cored location may include the step of coreing tissue at a target location such that the tissue core is removed from the target location to thereby create a core cavity at the target location. A sealing device may be positioned adjacent to the target location. The sealing device may be configured to seal at least a portion of the core cavity at the target location. The sealing device may be spaced apart from the target location (e.g., removed, separated, etc.).
[0006] A system and / or method for sealing tissue is described herein. An exemplary method may include the step of placing a port to provide access to a target location. An exemplary method may include the step of anchoring an anchor device to a surface at the target location through the port. An exemplary method may include the step of placing a sealing device adjacent to the target location through the port. An exemplary method may include the step of causing the sealing device to seal the target location. An exemplary method may include the step of placing a filler adjacent to the target location. The sealing device may minimize the escape of the filler from the target location.
[0007] A system and / or method for sealing tissue is described herein. An exemplary method may include the step of placing a sealing device adjacent to a target location in the lung while the lung is collapsing. An exemplary method may include the step of causing the sealing device to seal the target location. An exemplary method may include the step of placing a filler adjacent to the target location. The sealing device may minimize the escape of the filler from the target location. An exemplary method may include the step of separating (e.g., removing, separating, etc.) the sealing device from the target location.
[0008] A system and / or method for sealing a tissue is described herein. An exemplary method may include the step of anchoring an anchor device to a surface at a target location. An exemplary method may include the step of positioning a sealing device adjacent to the target location using the anchoring. An exemplary method may include the step of causing the sealing device to seal the target location. An exemplary method may include the step of positioning a filler adjacent to the target location. The sealing device may include the step of minimizing the escape of the filler from the target location.
[0009] A system and / or method for sealing tissue is described herein. An exemplary method may include the step of placing a fluid delivery device at a target location in the lung. An exemplary method may include the step of placing a filler at a target location. An exemplary method may include the step of moving the fluid delivery device away from the target location (e.g., removal, separation, etc.). Brief explanation of the drawing
[0010] The following drawings generally illustrate various examples discussed in this disclosure in an exemplary, but not limiting, manner. Figure 1 illustrates the application of an exemplary system for sealing tissues. Figure 2 illustrates the application of an exemplary system for sealing tissues. Figure 3 illustrates a flowchart of an exemplary method for sealing tissues. Figure 4 illustrates a flowchart of an exemplary method for sealing tissues. Figure 5 illustrates a flowchart of an exemplary method for sealing tissues. Figure 6 illustrates a flowchart of an exemplary method for sealing tissues. Figure 7 illustrates a flowchart of an exemplary method for coring and sealing tissues. Figures 8a, 8b, and 8c illustrate the application of an exemplary system for sealing tissues. Figures 9a and 9b illustrate the application of an exemplary system for sealing tissues. Figures 10a, 10b, and 10c illustrate the application of an exemplary system for sealing tissues. FIG. 11 illustrates a tissue resection device according to one embodiment of the present disclosure. Figure 12 shows a cross-sectional view of the tissue resection device of Figure 11. FIG. 13 illustrates a cross-sectional view of a tissue resection device according to one embodiment of the present disclosure. FIG. 14 illustrates a cross-sectional view of a tissue resection device according to one embodiment of the present disclosure. FIG. 15 illustrates a preferred anchor that can be used in a lesion removal method according to one embodiment of the present disclosure. FIG. 16 illustrates a series of cutting blades for use in a lesion removal method according to one embodiment of the present disclosure. FIG. 17 shows a tissue expander suitable for use in a lesion removal method according to one embodiment of the present disclosure. FIG. 18 illustrates a flowchart of an exemplary method for coring and sealing tissues. Specific details for implementing the invention
[0011] The present disclosure relates to systems and methods for the treatment of tissues such as cored tissue, perforated tissue, and / or removed tissue regions. Other tissues and locations may benefit from the disclosed systems and methods.
[0012] The present disclosure relates to a method and system for core a tissue and sealing a core cavity created by removing the tissue core. Such a method may include the step of placing a filler in the core cavity. The method may include the step of applying pressure to a portion of the core cavity, such as a wall defining the core cavity. The method may include the step of ablate a portion of the core cavity, such as a wall defining the core cavity. The method may include the step of causing a cavity closing device, such as a suture thread, a stapling device, an ultrasonic tissue sealing device, a bipolar radiofrequency sealing device, or any combination thereof, to close the tissue cavity. The method may include the step of closing the tissue cavity by placing a cavity sealing material, such as a cell graft, a hemostatic patch, a hemostatic agent such as fibrin or thrombin, a biological adhesive such as Dermabond®, or any combination thereof.
[0013] The method comprises: 1) placing an anchoring device in a tissue cavity; 2) placing a tissue access port in a tissue cavity; 3) placing a tissue sealing device in a tissue cavity (with or without the tissue access port, with or without a guide from the anchoring device); 4) causing the tissue sealing device to seal at least a portion of the working cavity; 5) introducing a filler into the working cavity (with or without a tissue access port, with or without a filler delivery device, with or without the tissue sealing device being placed in the tissue cavity, with or without the tissue sealing device being removed after sealing at least a portion of the tissue cavity, with or without the tissue access port); 6) tissue sealing material in a tissue cavity (with or without the tissue sealing device being placed in the tissue cavity, with or without the tissue sealing device being removed after sealing at least a portion of the tissue cavity, with or without the introduction of a filler into the tissue cavity). The method may include any combination or substitution of the steps of: 7) placing a cavity closure device adjacent to the tissue; and 8) causing the cavity closure device to close the tissue cavity (with or without any combination or substitution of the above steps preceding). As described herein, the method may be used to coring and / or sealing tissue at various target locations. Although a closed tissue is used as an example, it should not be limited thereto, and other target locations may be perforated or actively cored and may benefit from the disclosed sealing method.
[0014] The present disclosure relates to a method for delivering a filler, such as autologous blood, to a core site that can be used to seal and provide pneumostasis. As one example, when a tissue sample is cored and removed from the lung, it may be necessary to seal the core site to provide pneumostasis. As an additional example, pneumostasis may be achieved in the same surgical session as the tissue removal.
[0015] Although autologous blood has been described herein as an example, other fillers and additives may be used. For example, absorbable gelatin foam (hemostatic additives such as SURGIFOAM®, biologically oxidized regenerated cellulose (ORC)), fibrin / thrombin sprays, etc. As an additional example, a patient may have a rare disease called hemophilia in which their blood does not clot normally. Other patients may use blood thinners that inhibit blood clot formation. For such patients, to seal the cored cavity, thrombin and / or fibrinogen may be added to the autologous blood sample to aid in clot formation. Reactive polyethylene glycol (PEG), ammonium sulfate, ethanol, calcium chloride, and magnesium chloride may be added to the blood sample to aid in clot formation. Other sources for the blood to be used to seal the cored cavity are donated blood from other people or blood banks. Donated blood may be used with or without the anticoagulants described above.
[0016] A system and / or method for sealing tissue is described herein. An exemplary method may include the step of placing a port to provide access to a target site. The target site may comprise biological tissue. The target site may comprise lung tissue. The target site may comprise cored tissue. The target site may comprise perforated tissue. Other sites benefit from the disclosed method.
[0017] An exemplary method may include the step of anchoring an anchor device to a surface at a target location (e.g., through a port). Anchoring may be performed by any suitable device for securing the device to the lung. An exemplary method may include the step of positioning a sealing device adjacent to the target location (e.g., through a port). An exemplary method may include the step of positioning a sealing device adjacent to the target location using the anchoring device as a guide. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon having an array of radio frequency (RF) electrodes configured to ablate and seal tissue. The sealing device may include an inflatable balloon configured to seal tissue using a thermal fluid. The sealing device may include an inflatable balloon catheter. The sealing device may include an access port having an array of RF electrodes configured to ablate and seal tissue. The sealing device may include at least one microwave ablation probe.
[0018] An exemplary method may include a step of causing a sealing device to seal a target location. The step of causing the sealing device to seal a target location may include a step of ensuring that at least a portion of the sealing device is adjacent to a portion of the target location. An exemplary method may include a step of placing a filler adjacent to the target location. An exemplary method may include a step of placing a filler adjacent to the target location via a filler delivery device such as a catheter. The filler may include autologous blood, donated blood, recirculated blood, hemostatic adducts such as fibrin and / or thrombin, biological tissue adhesives such as Dermabond®, ORC, absorbable gelatin, or combinations thereof. The filler may promote airtightness. The filler may additionally promote hemostasis. Other materials may be used. The sealing device may minimize the escape of the filler from the target location.
[0019] As an example, the target location may include at least a portion of the lung. The lung may be allowed to collapse before the sealing device is placed adjacent to the target location. The lung may be allowed to be ventilated while the sealing device seals the target location. The sealing device may be separated from the target location (e.g., removed, separated, etc.) after the filler is placed.
[0020] A system and / or method for performing sealing is described herein. An exemplary method may include the step of positioning a sealing device adjacent to a target location in the lung. The sealing device may be positioned adjacent to the target location while the lung is collapsed. However, the lung may be ventilated. An exemplary method may include the step of causing the sealing device to seal the target location. An exemplary method may include the step of positioning the sealing device adjacent to the target location using an anchoring device as a guide. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon having an array of RF electrodes configured to excise and seal tissue. The sealing device may include an inflatable balloon configured to seal tissue using a thermal fluid. The sealing device may include an inflatable balloon catheter. The sealing device may include an access port having an array of RF electrodes configured to excise and seal tissue. The sealing device may include at least one microwave ablation probe. An exemplary method may include the step of positioning a filler adjacent to the target location. An exemplary method may include the step of placing a filler adjacent to a target site via a filler delivery device such as a catheter. The filler may comprise autologous blood, donated blood, recirculated blood, hemostatic adducts such as fibrin and thrombin, biological tissue adhesives such as Dermabond®, ORC, absorbable gelatin, or any combination thereof. The filler may promote airtightness. The filler may additionally promote hemostasis. Other materials may be used. A sealing device may minimize the escape of the filler from the target site.
[0021] A system and / or method for sealing is described herein. An exemplary method may include the step of placing a fluid delivery device at a target location in the lung. A sealing device may be placed adjacent to the target location while the lung is collapsing. A sealing device may be placed adjacent to the target location while the lung is ventilating. An exemplary method may include the step of placing a filler at the target location. An exemplary method may include the step of separating (e.g., removing, separating, etc.) the sealing device from the target location.
[0022] The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon having an array of RF electrodes configured to excise and seal tissue. The sealing device may include an inflatable balloon configured to seal tissue using a thermal fluid. The sealing device may include an inflatable balloon catheter. The sealing device may include an access port having an array of RF electrodes configured to excise and seal tissue. The sealing device may include at least one microwave ablation probe. The system and / or method described herein may allow coagulated blood to provide a seal to achieve airtightness. An exemplary method may include the step of placing a filler adjacent to a target location. An exemplary method may include the step of placing a filler adjacent to a target location via a filler delivery device such as a catheter. The filler may include autologous blood, donated blood, recirculated blood, hemostatic adducts such as fibrin and thrombin, biological tissue adhesives such as Dermabond®, absorbable gelatin, or any combination thereof. The filler can promote airtightness. The filler can additionally promote hemostasis. Other materials may be used. The sealing device can minimize the escape of the filler from the target location.
[0023] The target site may include a cavity. The cavity may be closed, for example, after sealing. Closing the cavity may involve using a biological tissue adhesive such as Dermabond®, cell grafts, hemostatic sealing patches, staple closure, sutures, etc.
[0024] FIG. 1 illustrates an exemplary system (100). The system (100) may include ports, such as a chest port (102), configured to provide access to a part of the body through a channel, for example. It should be understood that various channels or ports may be used throughout the body, and that the chest port (102) is illustrated as a non-limiting example. As an example, the chest port (102) is illustrated as being positioned adjacent to a rib (106) to provide access to the patient's lung (110). However, other locations may be used, and the chest port (102) (or other ports) may not be necessary. An anchor device (104) may be anchored to a tissue such as the lung (110). An exemplary anchor device is illustrated in FIG. 15 for example. However, any suitable device for anchoring to a target location (112) may be used. As illustrated, the anchor device (104) extends through the pleura (108) and the chest port (102) and anchors to tissue within the lung (110). The anchor device (104) may be anchored (e.g., disengaged) to tissue at a target location (112). The target location (112) may include a core location where a portion of lung tissue has been cored, perforated, or removed. The anchor device (104) may be positioned at the target location (112) while the lung is inflated. However, other processes may be performed while the lung is collapsing.
[0025] FIG. 2 illustrates an application of an exemplary sealing device (200). The sealing device (200) may include an inflatable balloon (202). Other sealing mechanisms may be used. The sealing device (200) may include a balloon catheter and / or be in contact with the balloon catheter. The balloon catheter may be a single-lumen balloon catheter. The balloon catheter may be a multi-lumen balloon catheter. The sealing device (200) may be positioned adjacent to a target location (112). In this way, the sealing device (200) can seal the target location (112) to minimize the escape of fluid or material from the target location (112). As an example, a filler (204) may be positioned at the target location (112) and may be sealed at the target location (112) by the sealing device (200). As an example, an inflatable balloon (202) can provide sealing while the lung (110) moves (e.g., inflates and deflates). The sealing device (200) can be implemented when the lung (110) is inflated or collapsed.
[0026] FIG. 3 illustrates a flowchart of an exemplary method (300). In 302, a port may be placed to provide access to a target location. A port (e.g., a chest port (102) (Fig. 1)) may be placed to provide access to a target location. A user may place a port to provide access to a target location. The target location may include biological tissue. The target location may include lung tissue. The target location may include cored tissue. The target location may include perforated tissue. The target location may include at least a portion of the lung.
[0027] In 304, the anchor device can be anchored to a surface at a target location. As an example, the user can anchor the anchoring device to a surface at a target location through a port.
[0028] In 306, the sealing device may be placed adjacent to the target location, for example, through a port. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon catheter. The lung may be allowed to collapse before the sealing device is placed adjacent to the target location. The lung may be allowed to ventilate while the sealing device seals the target location.
[0029] In 308, the sealing device may be configured to seal a target location. Configuring the sealing device to seal a target location may include at least a portion of the sealing device being adjacent to a portion of the target location.
[0030] In 310, the filler may be placed adjacent to the target location. The sealing device may minimize the escape of the filler from the target location. The filler may promote airtightness. The filler may contain autologous blood. The sealing device may be separated from the target location (e.g., removed, separated, etc.) after the filler is placed.
[0031] FIG. 4 illustrates a flowchart of an exemplary method (400). In 402, a sealing device may be positioned adjacent to a target location of the lung while the lung is collapsing. The target location may include lung tissue. The target location may include cored tissue. The target location may include perforated tissue. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon catheter.
[0032] In 404, the sealing device may be configured to seal a target location. Configuring the sealing device to seal a target location may include at least a portion of the sealing device being adjacent to a portion of the target location.
[0033] In 406, the filler may be placed adjacent to the target location. The sealing device may minimize the escape of the filler from the target location. The filler may promote airtightness. The filler may contain autologous blood. The sealing device may subsequently be separated from the target location (e.g., removed, separated, etc.).
[0034] FIG. 5 illustrates a flowchart of an exemplary method (500). In 502, an anchor device may be anchored to a surface at a target location. The target location may comprise biological tissue. The target location may comprise lung tissue. The target location may comprise cored tissue. The target location may comprise perforated tissue. The target location may comprise at least a portion of the lung.
[0035] In 504, the sealing device may be placed adjacent to the target location using anchoring. The sealing device may include an inflatable balloon. The sealing device may include an inflatable catheter. The lung may be allowed to collapse before the sealing device is placed adjacent to the target location.
[0036] In 506, the sealing device may be configured to seal a target location. Configuring the sealing device to seal a target location may include having at least a portion of the sealing device adjacent to a portion of the target location. The lungs may be allowed to ventilate while the sealing device seals the target location.
[0037] In 508, the filler may be placed adjacent to the target location. The sealing device may minimize the escape of the filler from the target location. The filler may promote airtightness. The filler may contain autologous blood. The filling device may be separated from the target location (e.g., removed, separated, etc.) after the filler is placed.
[0038] FIG. 6 illustrates a flowchart of an exemplary method (600). In 602, a fluid delivery device may be positioned at or adjacent to a target location of the lung while the lung is collapsing. The target location may comprise biological tissue. The target location may comprise tissue of the lung. The target location may comprise cored tissue. The target location may comprise perforated tissue. The target location may comprise at least a portion of the lung.
[0039] In 604, the filler can be placed at the target location. The filler can promote airtightness. The filler may contain autologous blood.
[0040] In 606, the fluid delivery device may be separated from the target location (e.g., removed, separated, etc.). The lung may be allowed to collapse before the fluid delivery device is placed adjacent to the target location.
[0041] FIG. 7 illustrates a flowchart of an exemplary method. In FIG. 702, tissue at a target location may be cored and the tissue core removed from the target location, thereby creating a core cavity at the target location. Coring the tissue at the target location may include cutting and sealing the tissue. Coring the tissue at the target location may include placing a tissue coring device adjacent to the target tissue location. The tissue coring device may include a first clamping element comprising a helical coil, a second clamping element positioned opposite at least a portion of the first clamping element, first and second electrodes configured for delivering radio frequency energy to seal the tissue, and / or a cutting element configured for cutting at least a portion of the sealed tissue. Other devices may be used.
[0042] Coring tissue at a target location may involve forming a tissue core using a tissue coring device. The target location may be a tissue location, for example, such as a lung. In 704, a sealing device may be positioned adjacent to the target location. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon catheter. In 706, the sealing device may be configured to seal at least a portion of the core cavity at the target location. Exemplary sealing procedures are described herein and may include, for example, filler, ablation, mechanical pressure, energy release (e.g., RF energy), etc. Configuring the sealing device to seal at least a portion of the core cavity at the target location may involve having at least a portion of the sealing device adjacent to the wall defining the core cavity. Configuring the sealing device to seal at least a portion of the core cavity at the target location may involve ablating the wall defining the core cavity. Causing the sealing device to seal at least a portion of the core cavity at the target location may include applying pressure to the wall defining the core cavity. The method (700) may include the step of placing a filler in the core cavity, and the sealing device minimizes the escape of the filler from the core cavity. The filler may include autologous blood. As an example, the target location may include at least a portion of the lung, and the method may further include the step of causing the lung to collapse before placing the sealing device adjacent to the target location. As an additional example, the target location may include at least a portion of the lung, and the method (700) may further include the step of allowing the lung to ventilate while the sealing device seals the target location. In 708, the sealing device may be separated from the target location (e.g., removed, separated, etc.).
[0043] An exemplary system for implementing one or more of the methods of the present disclosure may include a guided anchor. An exemplary system may include a single-lumen balloon catheter. An exemplary system may include a multi-lumen balloon catheter. An exemplary system may include a coring device. After coring by the coring device, as shown in FIG. 1, the anchor may be introduced into the tissue cavity to ensure access to the cored location. The chest port may be removed, and the lung may be collapsed. The balloon catheter may be inserted over the anchor. When the balloon catheter is in the chest cavity, the balloon catheter may be inflated. The inflated balloon catheter may be moved forward and pushed slightly against the lung tissue. Autologous blood may be injected into the core location through the inflated balloon catheter. The inflated balloon catheter and autologous blood may be held in place for a predetermined period (e.g., 1 minute) as shown in FIG. 2 to allow the blood to clot at the core location. The lung may be allowed to resume ventilation. The inflated balloon catheter is allowed to move the lung up and down while maintaining contact with the lung, allowing blood at the core location to continue facilitating further coagulation. The balloon catheter may be deflated. The balloon catheter and anchor may be removed after a predetermined period (e.g., 3 minutes). Autologous blood may coagulate at the core location to provide airtightness.
[0044] In one embodiment, an anchor and / or balloon catheter may be used to deposit autologous blood at the core location as the lung collapses. The anchor and / or balloon catheter may be removed after the autologous blood has been delivered. The blood may be allowed to clot in place for a predetermined period (e.g., 5 minutes) before the lung is allowed to resume ventilation.
[0045] An exemplary system can allow autologous blood to be delivered to the core location. Other fillers may be used.
[0046] An exemplary system may allow coagulated blood to provide a seal to achieve airtightness.
[0047] FIGS. 8a-8c illustrate exemplary applications. As illustrated, once the target location is cored and the tissue is removed, it may be necessary to resect the tissue wall of the cavity. As such, the following resection method may be used. For example, a rotating resection probe may be used. FIG. 8a illustrates a cored cavity (812) within the tissue (810), and a cavity sheath (802) is in place to keep the cavity open. A rotating probe (800) is then inserted into the cavity sheath as illustrated in FIG. 8b. The probe (800) may be equipped with an energy source, such as an array of energy heads or a continuous energy strip. The energy may be in the form of a microwave, RF, or other output. With the probe (800) in place, the cavity sheath (802) may remain in place or be removed. Subsequently, while energy is applied, the probe / energy head is rotated to provide radially continuous ablation on the walls and bottom tissue (810) of the cavity as shown in FIG. 8c.
[0048] FIGS. 9a-9b illustrates exemplary applications. As illustrated, a hot balloon catheter may be used. For example, as illustrated in FIG. 9a, the balloon catheter (900) may be positioned into a cavity (912) formed in tissue (910), and the cavity sheath may be removed to expose the cavity (912) to be resected. The balloon (900) may then be inflated with a hot fluid or hot air / gas to remove the cavity wall tissue (910), as illustrated in FIG. 9b.
[0049] FIGS. 8-9 illustrates exemplary examples, but other methods of removal or energy release may be used to seal the tissue. For example, a shaped mesh catheter may be used. In this way, a catheter having a collapsed mesh shape may be inserted into the cavity and the cavity sheath is removed. The mesh may then be expanded, and suction may be applied to pull the tissue into contact with the mesh. Energy, such as RF energy, may then be applied to remove the cavity tissue wall.
[0050] FIGS. 10a-10c illustrate an exemplary application. As illustrated, when a target location is cored and the tissue core is removed, it may be necessary to seal the tissue walls of the cut cavity. As such, the following exemplary procedure may be utilized. The device (1000) may include a fluid conduit (1001) and an inflatable absorbable balloon (1002). The balloon (1002) may be coated on the outside with an absorbable bio-adhesive to seal against the tissue of the cored cavity after cored, as illustrated in FIGS. 10a-10b. If a deflated balloon (1002) can be positioned at the required location, the balloon (1002) may be inflated with CO2 (or other fluid), for example, through the fluid conduit (1001), so that the bio-adhesive pressurizes against the tissue walls of the cored cavity to achieve a seal to prevent air leakage. A balloon (1002) filled with CO2 can be pressurized to an appropriate pressure and can remain inside a cored cavity as shown in FIG. 10c.
[0051] Various methods, devices, and systems can be used to coring and remove tissues.
[0052] A method for removing a tissue lesion may include the steps of: introducing a tissue resection device to a target tissue location; causing the tissue resection device to resect a core of tissue from the target tissue location; and removing the core of tissue from the body. The core of tissue may include at least a portion of the tissue lesion. The method may further include the step of creating a core cavity at the target tissue location. The method may further include the step of inserting a sleeve into the core cavity. The method may further include the step of delivering radio frequency energy through the core cavity. The method may further include the step of delivering chemotherapy through the core cavity. The method may further include the step of delivering microwave radiation through the core cavity. The method may further include the step of delivering thermal energy through the core cavity. The method may further include the step of delivering ultrasonic energy through the core cavity. The tissue resection device may be configured for the delivery of radio frequency energy. The tissue resection device may be configured for mechanical transsection. The tissue resection device may include the delivery of radio frequency energy and mechanical compression. The method may further include the step of amputating the core of the tissue from the target tissue location. As an example, the means for amputating the core of the tissue may include mechanical transverse cutting. As a further example, the means for amputating the core of the tissue may include the delivery of radio frequency energy. The means for amputating the core of the tissue may include the delivery of radio frequency energy and mechanical compression. The means for amputating the core of the tissue may include transverse cutting with an energy-applied wire. Other devices may be used.
[0053] A method for removing a tissue core may include the steps of introducing a tissue resection device to a target tissue location, causing the tissue resection device to resect the tissue core from the target tissue location, and removing the tissue core from the body. The method may further include the step of creating a core cavity at the target tissue location. The method may further include the step of inserting a sleeve into the core cavity. The method may further include the step of delivering radio frequency energy through the core cavity. The method may further include the step of delivering chemotherapy through the core cavity. The method may further include the step of delivering microwave radiation through the core cavity. The method may further include the step of delivering thermal energy through the core cavity. The method may further include the step of delivering ultrasonic energy through the core cavity. The tissue resection device may be configured for the delivery of radio frequency energy. The tissue resection device may be configured for mechanical transverse cutting. The tissue resection device may be configured for the delivery of radio frequency energy and mechanical compression. The method may further include the step of cutting the tissue core from the target tissue location. Means for cutting the tissue core may include mechanical transverse cutting. Means for cutting the core of the tissue may include the delivery of radio frequency energy. Means for cutting the core of the tissue may include the delivery of radio frequency energy and mechanical compression. Means for cutting the core of the tissue may include transverse cutting with an energy-applied wire.
[0054] A method for removing a tissue core may include the step of introducing a tissue resection device to a target tissue location. The tissue resection device may include one or more of a first clamping element comprising a helical coil and a first electrode or a second clamping element comprising a second electrode. If a second clamping element is included, the second clamping element may be positioned to face at least a portion of the first clamping element. The method may further include the step of causing the tissue resection device to resect the tissue core from the target tissue location and the step of removing the tissue core from the body. The method may further include the step of creating a core cavity at the target tissue location. The method may further include the step of inserting a sleeve into the core cavity. The method may further include the step of delivering radiofrequency energy through the core cavity. The method may further include the step of delivering chemotherapy through the core cavity. The method may further include the step of delivering microwave radiation through the core cavity. The method may further include the step of delivering thermal energy through the core cavity. The method may further include the step of delivering ultrasonic energy through the core cavity. A tissue resection device may be configured to resect a tissue core and may include the delivery of radio frequency energy. A tissue resection device may be configured to resect a tissue core and may include mechanical transverse cutting. A tissue resection device may be configured to resect a tissue core and may include the delivery of radio frequency energy and mechanical compression. The method may further include the step of cutting the tissue core from a target tissue location. Means for cutting the tissue core may include mechanical transverse cutting. Means for cutting the tissue core may include the delivery of radio frequency energy. Means for cutting the tissue core may include the delivery of radio frequency energy and mechanical compression.Means for cutting the core of the tissue may include transverse cutting with an energy-applied wire.
[0055] A method for sealing a biological fluid vessel may include the step of penetrating a target tissue location comprising at least a portion of at least one biological fluid vessel with a helical tissue sealing mechanism. The helical tissue sealing mechanism may include a penetrating element and a clamping element of the helical. The method may include the step of causing the helical tissue sealing mechanism to apply mechanical pressure to at least one target biological fluid vessel and the step of sealing at least one target biological fluid vessel by delivering energy. The penetrating element of the helical may include a clamping element. Mechanical pressure may be applied between the penetrating element and the clamping element of the helical. The method may further include a second clamping element. Mechanical pressure may be applied between the first and second clamping elements. The delivered energy may include unipolar radio frequency energy. The delivered energy may include bipolar radio frequency energy. The delivered energy may include thermal energy. The delivered energy may include ultrasonic energy.
[0056] A method for sealing a biological fluid tube may include the steps of penetrating a target tissue location with a helical penetrating element, applying mechanical pressure to the target tissue by adjusting the pitch of the helical penetrating element, and delivering energy to seal at least one biological fluid tube in the target tissue. The helical penetrating element may include a plurality of tissue sealing electrodes. The delivered energy may include unipolar radiofrequency energy. The delivered energy may include bipolar radiofrequency energy. The delivered energy may include thermal energy. The delivered energy may include ultrasonic energy.
[0057] A tissue excision device may include a first clamping element comprising a helical coil, a second clamping element positioned opposite to at least a portion of the first clamping element, first and second electrodes configured for the delivery of radio frequency energy to seal the tissue, and a cutting element configured for transverse cutting of at least a portion of the sealed tissue. The tissue excision device may further include a first actuator operable to drive the first or second clamping element to apply mechanical pressure to the tissue, and a second actuator operable to drive the cutting element to transversely cut the tissue. The helical coil may include first and second adjacent coil segments. The first coil segment may include an open ring that is entirely planar. The first coil segment may be helical and may have a pitch of zero. The second coil segment may be helical and may have a non-zero pitch. The second coil segment may have a variable pitch. The first coil segment may be helical and may have a first pitch, and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable. The first electrode may be included as at least a part of the first clamping element. The second electrode may be included as at least a part of the second clamping element. The helical coil may include a blunt tip. The first and second electrodes may include surface profiles that match or substantially match. At least a part of the cutting element may include a sharpened edge. The cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The cutting element may include an ultrasonic blade. The tissue resection device may include a second cutting element configured to cut the core of the tissue from the target tissue location. At least a part of the second cutting element may include a sharpened edge.The second cutting element may include at least one electrode configured for the delivery of radio frequency energy. The second cutting element may include a wire to which energy is applied. The second cutting element may include a suture. The tissue resection device may further include an actuator operable to drive the second cutting element to transversely cut the tissue.
[0058] A tissue resection device may include a first clamping element having a helical coil disposed at a distal end, a second clamping element disposed opposite to at least a portion of the first clamping element, first and second electrodes configured for delivering radio frequency energy to seal tissue, and a cutting element configured for transversely cutting at least a portion of the sealed tissue. The tissue resection device may further include a first actuator operable to drive the first and second clamping elements to apply mechanical compression to the tissue, and a second actuator operable to drive the cutting element to transversely cut the tissue. The helical coil may include first and second adjacent coil segments. The first coil segment may include an open ring that is entirely flat. The first coil segment may be helical and may have a pitch of zero. The second coil segment may be helical and may have a non-zero pitch. The second coil segment may have a variable pitch. The first coil segment may be helical and may have a first pitch, and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable. The first electrode may be included as at least a part of the helical coil. The first electrode may be included as at least a part of the first clamping element. The second electrode may be included as at least a part of the second clamping element. The helical coil may include a blunt tip. The first and second electrodes may include surface profiles that match or substantially match. At least a part of the cutting element may include a sharpened edge. The cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The cutting element may include an ultrasonic blade. The tissue resection device may further include a second cutting element configured to cut the core of the tissue from the target tissue location. At least a part of the second cutting element may include a sharpened edge.The second cutting element may include at least one electrode configured for the delivery of radio frequency energy. The second cutting element may include a wire to which energy is applied. The second cutting element may include a suture. The tissue resection device may further include an actuator operable to drive the second cutting element to transversely cut the tissue.
[0059] A tissue excision device may include a first clamping element comprising a helical coil and a first electrode, and a second clamping element comprising a second electrode and positioned opposite to at least a portion of the first clamping element. The first and second clamping elements may be configured for (a) the delivery of radio frequency energy for sealing the tissue and (b) the application of mechanical pressure for cutting the tissue. The tissue excision device may further include a first actuator operable to drive the first or second clamping element to apply mechanical pressure to the tissue, and a second actuator operable to drive a cutting element to transversely cut the tissue. The helical coil may include first and second adjacent coil segments. The first coil may include an open ring that is planar in its entirety. The first coil segment may be helical and may have a pitch of zero. The second coil segment may be helical and may have a non-zero pitch. The second coil segment may have a variable pitch. The first coil segment may be helical, and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable. The first electrode may be included by at least a portion of the helical coil. The first electrode may be included by at least a portion of the first clamping element. The second electrode may be included by at least a portion of the second clamping element. The helical coil may include a blunt tip. The first and second electrodes may include surface profiles that match or substantially match. At least a portion of the cutting element may include a sharpened edge. The cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The cutting element may include an ultrasonic blade. The tissue resection device may further include a second cutting element configured to cut the core of the tissue from the target tissue location. At least a portion of the second cutting element may include a sharpened edge.The second cutting element may include at least one electrode configured for the delivery of radio frequency energy. The second cutting element may include a wire to which energy is applied. The second cutting element may include a suture. The tissue resection device may further include an actuator operable to drive the second cutting element to transversely cut the tissue.
[0060] A surgical instrument system for tissue resection may include an end effector operable to cut and seal tissue, and a generator configured to provide power to the end effector having first and second electrodes for sealing tissue. The end effector may include a first clamping element comprising a helical coil, a second clamping element positioned opposite to at least a portion of the first clamping element, first and second electrodes configured for delivering radio frequency energy for sealing tissue, and a cutting element configured for transverse cutting of at least a portion of the sealed tissue. The surgical instrument system further includes a controller communicating with the generator, and the controller is configured to control the generator to provide sufficient radio frequency energy to the first and second electrodes of the end effector for sealing tissue based on at least one sensed operating condition of the end effector. The controller may be configured to sense the presence of tissue in the end effector. The controller may be configured to sense the presence of tissue in the end effector based on a measured impedance level associated with the first and second electrodes. The controller may be configured to detect the presence of tissue in the end effector by sensing the amount of force applied to at least one of the first and second clamping elements. The controller may be configured to sense the position of the cutting element relative to at least one of the first and second clamping elements. The controller may be configured to control a generator to provide radio frequency energy to the end effector when the second actuator is driven and no tissue is detected in the end effector. The controller may be configured to control a generator to provide a continuous amount of radio frequency energy. The controller may be configured to control a generator to automatically provide an increase or decrease in the amount of radio frequency energy.The system may further include a first actuator operable to apply mechanical pressure to tissue by driving a first or second clamping element, and a second actuator operable to transversely cut tissue by driving a cutting element. The helical coil may include first and second adjacent coil segments, and the first coil segment includes a first electrode. The first coil segment may include an open ring that is planar in its entirety. The first coil segment may be helical and may have a pitch of zero. The second coil segment may be helical and may have a non-zero pitch. The second coil segment may have a variable pitch. The first coil segment may be helical and may have a first pitch, and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable. The first electrode may be included as at least a part of the helical coil. The first electrode may be included as at least a part of the first clamping element. The second electrode may be included as at least a part of the second clamping element. The helical coil may include a blunt tip. The first and second electrodes may include surface profiles that match or substantially match. At least a portion of the cutting element may include a sharpened edge. The cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The cutting element may include an ultrasonic blade. The tissue resection device may be configured to cut the core of the tissue from a target tissue location. At least a portion of the second cutting element may include a sharpened edge. The second cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The second cutting element may include an energy-applied wire. The second cutting element may include a suture line. The tissue resection device may further include an actuator operable to drive the second cutting element to transversely cut the tissue.
[0061] A tissue resection device may include a first clamping element comprising a helical coil, a second clamping element positioned to face at least a portion of the first clamping element, first and second electrodes configured for the delivery of radio frequency energy to seal the tissue, a first cutting element configured for transverse cutting of at least a portion of the sealed tissue, first and second ligation elements, and a second cutting element positioned between the first and second ligation elements. The tissue resection device may further include a first actuator operable to drive the first or second clamping element to apply mechanical pressure to the tissue, and a second actuator operable to drive the coating element to transversely cut the tissue. The helical coil may include first and second adjacent coil segments. The first coil segment may include an open ring that is entirely flat. The first coil segment may be helical and may have a pitch of zero. The second coil segment may be helical and may have a non-zero pitch. The second coil segment may have a variable pitch. The first coil segment may be helical and may have a first pitch, and the second coil segment may be helical and may have a second pitch, and at least one of the first and second pitches may be variable. The first electrode may be included as at least a part of the helical coil. The first electrode may be included as at least a part of the first clamping element. The second electrode may be included as at least a part of the second clamping element. The helical coil may include a blunt tip. The first and second electrodes may include surface profiles that match or substantially match. At least a part of the cutting element may include a sharpened edge. The cutting element may include at least one electrode configured for the delivery of radiofrequency energy. The cutting element may include an ultrasonic blade. The tissue resection device may further include a second cutting element configured to cut the core of the tissue from the target tissue location.At least a portion of the second cutting element may include a sharpened edge. The second cutting element may include at least one electrode configured for the delivery of radio frequency energy. The second cutting element may include a wire to which energy is applied. The second cutting element may include a suture line. The tissue resection device may further include an actuator operable to drive the second cutting element to transversely cut the tissue.
[0062] The tissue sealing mechanism may include a helical coil having an overall obround cross section and a tapered point disposed at the distal end, first and second helical tissue sealing surfaces provided by parallel planar surfaces of the helical coil, a first electrode disposed on the first helical tissue sealing surface and a second electrode disposed on the second helical tissue sealing surface, wherein the first and second electrodes are configured to apply anode radiofrequency energy for sealing the tissue. The helical coil may include first and second adjacent coil segments. The helical coil may include a blunt tip. The first and second electrodes may have substantially matching surface profiles. The first and second helical tissue sealing surfaces may further include a plurality of electrodes configured for the delivery of anode radiofrequency energy.
[0063] FIGS. 11-17 illustrates an exemplary device that can be used to enable a coring process as described herein. For example, the ablation device of the present invention may include an energy-based array capable of penetrating tissue toward a target lesion. In one embodiment illustrated in FIG. 11, the tissue ablation device (1100) comprises an outer tube (1105), and the outer tube (1105) is provided with a distal edge profile and an inner diameter (IDouter). A coil (1110) is attached to the outer tube (1105), wherein the coil rotation is spaced apart from and opposite to the distal end of the outer tube (1105). The coil (1110) preferably has a slightly blunt tip (1115) that is sharp enough to penetrate tissues such as the pleura and parenchyma, while minimizing the possibility of penetrating blood vessels. In some embodiments, the coil (1110) may take the form of a spiral having a fixed pitch or a variable pitch. The coil (1110) may also have a variable cross-sectional geometry. The electrode (1130) may be placed on the surface or embedded within the coil (1110).
[0064] In some embodiments, as illustrated in FIG. 11, the coil (1110) may include a plurality of adjacent coil segments, e.g., coil segments (1120 and 1125). The coil segment (1120) includes a helical member having a pitch of 00, e.g., an open ring structure that is entirely planar, and has an inner diameter (IDcoil) and an outer diameter (ODcoil). The coil segment (1125) may include a helical structure of a fixed pitch or a variable pitch and a fixed or variable cross-sectional geometry. In these embodiments, the electrode (1130) may be placed on the surface of the coil segment (1120) or embedded in the coil segment (1120).
[0065] A central tube (1200) having an outer diameter (ODcentral) and an inner diameter (IDcentral) may be provided, having a distal end with an edge profile comprising one or more surface segments. As illustrated in FIG. 12, an electrode (1205) is placed on or embedded therein of at least one surface segment. The central tube (1200) is slidably placed within an outer tube (1105) such that the electrode (1205) faces at least a portion of the electrode (1130) and overlaps at least a portion of the electrode (1130). The space between the electrode (1205) and the electrode (1130) may be referred to as a tissue clamping zone. According to one aspect of the present disclosure, ODcentral > IDcoil and ODcoil > IDcentral. In some embodiments, ODcentral is nearly identical to ODcoil. Accordingly, the central tube (1200) is advanced toward the coil (1110) through the tissue clamping zone so that the electrode (1205) can be adjacent to the electrode (1130).
[0066] The cutting tube (1300) can be slidably positioned within the central tube (1200). The distal end of the cutting tube (1300) is provided with a knife edge to facilitate tissue cutting.
[0067] To enable tissue resection, the resection device (1100) can be inserted into the tissue, and the outer tube (1105) can be advanced a predetermined distance toward the target. The coil segment (1125) can allow the device to penetrate the tissue in a manner similar to a corkscrew. As the coil segment (1125) penetrates the tissue, any vessel within its path can be moved to the flat coil segment (1120) or pushed out of the coil (1100) for subsequent rotation. The coil tip (1115) can be made blunt enough to minimize the possibility of penetrating blood vessels, while still being sharp enough to penetrate some tissues such as the pulmonary pleura and parenchyma. The central tube (1200) can then be advanced a predetermined distance toward the target. Any vessel placed in the tissue clamping zone will be clamped between the electrode (1130) and the electrode (1205). The tube can then be sealed by applying anode energy to the electrode (1130) and electrode (1205). Once the blood vessel is sealed, the cutting tube (1300) can be advanced to core the tissue to the depth reached by the outer tube (1105). The sealing and cutting process can be repeated to create a core of the required size.
[0068] According to one aspect of the present disclosure, the resection device may be further configured to dissect a target lesion and seal tissue near the dissection site. As illustrated in FIG. 13, to facilitate dissection and sealing, the central tube (1200) is provided with a ligation snare (1230), first and second ligation electrodes (1215 and 1220), and a cutting snare (1225). As used herein, the word “snare” refers to an elastic line, e.g., a string or wire. The inner wall surface of the central tube (1200) may include upper and lower circumferential groove paths (1212 and 1214) positioned near the distal end. The first and second ligation electrodes (1215 and 1220) are positioned on the inner wall of the central tube (1200), and the lower circumferential groove (1214) may be located between them. The upper groove path (1212) can be positioned axially over the ligation electrodes (1215 and 1220).
[0069] The ligation snare (1230) may be placed in the lower circumferential groove (1214) and extend along the outer wall surface through the central tube (1200) and axially to the snare drive mechanism (not shown). The cutting snare (1225) may be placed in the upper circumferential groove (1212) and extend along the outer wall surface through the central tube (1200) and axially to the snare drive mechanism (not shown). The outer surface of the central tube (1200) is provided with a plurality of axially extended groove paths that accommodate the cutting snare (1225) and the ligation snare (1230) and communicate with the upper and lower circumferential groove paths (1212 and 1214). Additionally, electrode leads for the ligation electrodes (1215 and 1220) may extend to an energy source through the axially extended groove paths.
[0070] In operation, the resection device of the present embodiment can separate and seal a tissue core. The cutting tube (1300) may be retracted to expose a ligation snare (1230) preferably formed by an elastic line, such as a suture line. The ligation snare (1230) may be engaged to hook onto the tissue and pull the tissue against the inner wall surface between the first and second ligation electrodes (1215 and 1220). Bipolar energy is then applied to the first and second electrodes (1215 and 1220) to seal, i.e., cauterize, the tissue. Once sealed, the cutting tube (1300) may be further retracted to expose a cutting snare that can then be driven to cut the tissue core upstream from the point where the tissue is sealed (ligation point). In some embodiments, the cutting snare (1225) may have a smaller diameter than the ligation snare (1230). A smaller diameter facilitates tissue slicing. Therefore, the excision device (1100) according to the present embodiment can both create a tissue core and separate the core from surrounding tissue.
[0071] In an alternative embodiment, the resection device of the present disclosure is provided with a single snare positioned between ligation electrodes that perform both ligation and cutting of the tissue. In this embodiment, the single snare can first pull the tissue against the inner wall surface of the central tube between the ligation electrodes (1215 and 1220). Then, bipolar energy is applied to the first and second electrodes (1215 and 1220) to seal, i.e., zap, the tissue. Once sealed, the snare is pulled further to cut the tissue core.
[0072] In another embodiment, cutting and sealing may be performed without using electrodes. In this embodiment, the ligation snare (1230) may include, for example, a set of knots (1235 and 1240) tightened under load as shown in FIG. 14. Ligation is performed by shortening the cutting tube (1300) to expose the ligation snare (1230) and driving the ligation snare (1230) to snare the tissue as the ligation knots are tightened. When the tissue is snareed, the cutting tube (1300) is further shortened to expose the cutting snare (1225), which can then be operated to cut the tissue core upstream from the point where the tissue is snareed.
[0073] The present disclosure relates to a method and system for using a resection device to remove a tissue lesion, e.g., a lung lesion. The method generally comprises the steps of anchoring a lesion targeted for removal, creating a channel within the tissue leading to the target lesion, creating a tissue core containing the anchored lesion, ligating the tissue core and sealing the surrounding tissue, and removing the tissue core containing the target lesion from the channel.
[0074] The anchoring step may be performed by any suitable structure for securing the device to the lung. Once the lesion is anchored, a channel may be created to facilitate the insertion of the resection device (1100). The channel may be created by making an incision within the lung region and inserting an expander and a port into the incision. A tissue core containing the anchored lesion may be created. According to the present disclosure, the resection device (1100) may be used to create the tissue core, ligate the tissue core, seal the tissue core, and cut it from the surrounding tissue as described above. The tissue core may then be removed from the channel. As an example, a cavity port may be inserted into the channel to facilitate subsequent treatment of the target lesion site through energy-based tumor removal, such as chemotherapy and / or radiation. As a further example, the cavity port may be placed around the tissue resection device. When the device is removed from the tissue site, the cavity port may remain in place or be removed.
[0075] The anchor illustrated in FIG. 15 may be suitable for use in carrying out the method for removing tissue lesions described herein. The anchor may comprise an outer tube (1422) having a sufficiently sharp edge to penetrate chest cavity tissue and lungs without excess damage, and an inner tube (1424) disposed within the outer tube (1422). One or more branches or fingers (1426) formed or pre-formed from a shape memory material, such as nitinol, may be attached to the ends of the inner tube (1424). The outer tube (1422) may be shortened over the inner tube (1424) so that when the outer tube (1422) is shortened, the branches (1426) may take on their pre-formed shape as illustrated. According to the present disclosure, the outer tube (1422) may be shortened after penetrating the lung lesion, thereby causing the branches (1426) to engage with the lung lesion. Other suitable anchors may include coil and suction-based structures.
[0076] The incision blades illustrated in FIG. 16 are suitable for use in performing the method for removing tissue lesions described herein. Once the anchor (1400) is installed, it may be desirable to create a small cut or incision to facilitate the insertion of the chest wall tissue expander. The incision blades (1605) may be used to create larger incisions. The incision blades (1605) may be continuous. The incision blades (1605) may include a central aperture that allows them to advance coaxially along the anchor needle (1405) to create larger incisions in the chest wall, and each successive blade may be larger than the previous blade, thereby increasing the width of the incision.
[0077] The tissue expander described in FIG. 17 may be suitable for use in performing the method for removing tissue lesions described herein. The tissue expander may include any suitable device for creating channels in organic tissue. In one embodiment, the tissue expander assembly includes a single cylindrical rod with a rounded end (1510) or a cylindrical rod with a rigid sleeve array (1515). Successive tissue expanders may advance coaxially along an anchor needle to create a tissue tube or channel within the chest wall, and each successive expander is larger than the previous expander, thereby increasing the diameter of the channel. When the last expander with a rigid sleeve is deployed, the internal rod (1505) is removed, leaving the rigid sleeve in the coastal space between the ribs to create a direct passage to the pulmonary pleura.
[0078] Any tissue resection device capable of penetrating lung tissue and creating a tissue core containing a target lesion may be suitable for use in performing the method for removing a tissue lesion described herein. The aforementioned tissue resection device (1100) is preferred.
[0079] When the tissue resection device (1100) is removed, a small channel within the lung from which the target lesion has been removed may exist. This channel may be used to introduce an energy-based resection device and / or local chemotherapy depending on the results of the tissue diagnosis. Thus, the method and system of the present disclosure can be used not only to ensure that an effective biopsy is performed but also to achieve complete removal of minimal lung tissue.
[0080] FIG. 18 illustrates a flowchart of an exemplary method. In FIG. 1802, tissue at a target location may be cored so that the tissue core is removed from the target location and thereby a core cavity may be created at the target location. Coring the tissue at the target location may include transversely cutting and sealing the tissue. Coring at the target location may include placing a tissue coring device adjacent to the target tissue location. The tissue coring device may include a first clamping element comprising a helical coil, a second clamping element positioned opposite at least a portion of the first clamping element, first and second electrodes configured for the delivery of radio frequency energy to seal the tissue, and / or a cutting element configured for transversely cutting at least a portion of the sealed tissue. Other devices may be used.
[0081] In 1804, a port may be positioned to provide access to a target location. A port (e.g., a chest port (102) (Fig. 1)) may be positioned to provide access to a target location. A user may position a port to provide access to a target location. The target location may include biological tissue. The target location may include lung tissue. The target location may include cored tissue. The target location may include perforated tissue. The target location may include at least a portion of the lung.
[0082] In 1806, an anchor device can be anchored to a surface at a target location. As an example, a user can anchor the anchor device to a surface at a target location through a port.
[0083] In 1808, the sealing device may be placed adjacent to the target location, for example, through a port. The sealing device may include an inflatable balloon. The sealing device may include an inflatable balloon catheter. The lung may be allowed to collapse before the sealing device is placed adjacent to the target location. The lung may be allowed to ventilate while the sealing device seals the target location.
[0084] In 1810, the sealing device may be configured to seal a target location. Configuring the sealing device to seal a target location may include at least a portion of the sealing device being adjacent to a portion of the target location.
[0085] The present disclosure may include at least the following aspects.
[0086] Aspect 1. A method for sealing tissue at a target location, comprising the steps of: placing a sealing device comprising an inflatable balloon in a cavity at a target location of the tissue; causing the balloon to be inflated using a fluid so that at least a portion of the inflated balloon is adjacent to the wall of the cavity and seals at least a portion of the cavity; and separating the sealing device from the target location.
[0087] Aspect 2. A method of Aspect 1, wherein the target location includes lung tissue.
[0088] Aspect 3. A method in which, in any one of aspects 1-2, the fluid has a temperature sufficient to remove at least a portion of the cavity wall.
[0089] Aspect 4. A method of any one of Aspects 1-3, wherein the cavity comprises a cored tissue having a measurable radius, and the balloon expands based on the radius.
[0090] Aspect 5. In any one of aspects 1-4, the target location comprises at least a portion of the lung, and the method further comprises the step of causing the lung to collapse before placing the sealing device in the cavity.
[0091] Aspect 6. In any one of Aspects 1-5, the target location comprises at least a portion of the lung, and the method further comprises the step of allowing the sealing device to ventilate while sealing the target location.
[0092] Aspect 7. A method in any one of Aspects 1-6, wherein the bio-adhesive is placed on the surface of the balloon and the bio-adhesive comes into contact with the wall of the cavity when the balloon is inflated.
[0093] Aspect 8. A method in any one of Aspects 1-7, wherein the balloon is configured to deliver RF energy to at least a portion of the cavity wall.
[0094] Aspect 9. A method of any one of Aspects 1-8, further comprising the step of shrinking the balloon for removal from the cavity.
[0095] Aspect 10. A method for sealing tissue at a target location, comprising the steps of: placing a cavity sheath adjacent to a tissue cavity to minimize the collapse of the tissue cavity; placing a sealing device including an inflatable balloon in the tissue cavity; removing the cavity sheath from the tissue cavity so that the inflatable balloon remains placed in the tissue cavity; and causing the balloon to be inflated using a fluid so that at least a portion of the inflated balloon is adjacent to the wall of the tissue cavity and seals at least a portion of the tissue cavity.
[0096] Aspect 11. In the method of Aspect 10, a tissue cavity is formed in the lung.
[0097] Aspect 12. A method according to any one of Aspects 10-11, wherein the tissue cavity comprises cored tissue.
[0098] Aspect 13. A method in which, in any one of Aspects 10-12, the fluid has a temperature sufficient to remove at least a portion of the wall of the tissue cavity.
[0099] Aspect 14. A method according to any one of Aspects 10-13, wherein the tissue cavity comprises cored tissue having a measurable radius and the balloon is expanded based on the radius.
[0100] Aspect 15. In any one of Aspects 10-14, the tissue cavity is placed in the lung, and the method further comprises the step of causing the lung to collapse before the sealing device is placed in the tissue cavity.
[0101] Aspect 16. A method of any one of Aspects 10-15, further comprising the step of placing a tissue cavity in the lung and allowing the lung to ventilate while a sealing device seals the tissue cavity.
[0102] Aspect 17. A method of any one of Aspects 10-16, further comprising the step of shrinking a balloon for removal from a tissue cavity.
[0103] Aspect 18. A method according to any one of Aspects 10-17, wherein the bio-adhesive is placed on the surface of the balloon and the bio-adhesive comes into contact with the wall of the cavity when the balloon is inflated.
[0104] Aspect 19. A method in any one of Aspects 10-18, wherein the balloon is configured to deliver RF energy to at least a portion of the cavity wall.
[0105] Aspect 20. A method of any one of Aspects 10-19, further comprising the step of removing the sealing device from the tissue cavity.
[0106] Aspect 21. A sealing device for sealing a tissue cavity, comprising: a balloon catheter configured to extend an inflatable balloon into the tissue cavity; and a source of fluid configured to fluidly communicate with the inflatable balloon and fill the balloon with fluid to inflate the balloon to a controlled radius.
[0107] Aspect 22. A sealing device of Aspect 21, wherein the tissue cavity is formed in the lung.
[0108] Aspect 23. A sealing device according to any one of Aspects 21-22, wherein the tissue cavity comprises a cored tissue having a measurable radius and the balloon expands based on the measurable radius.
[0109] Aspect 24. A sealing device according to any one of Aspects 21-23, wherein the fluid has a temperature sufficient to remove at least a portion of the wall of the tissue cavity.
[0110] Aspect 25. A sealing device according to any one of Aspects 21-24, wherein a bio-adhesive is placed on the surface of a balloon and the bio-adhesive comes into contact with the wall of a cavity when the balloon is inflated.
[0111] Aspect 26. A sealing device according to any one of Aspects 21-25, wherein a balloon is configured to transfer RF energy to at least a portion of the wall of the cavity.
[0112] Although what is considered to be the most practical and desirable embodiment has been illustrated and described, it is evident to those skilled in the art that attempts deviating from the specific design and method described and illustrated may be proposed and used without departing from the spirit and scope of the invention. For example, a system and method for the removal of a lesion from the lung have been described herein. It will be acknowledged to those skilled in the art that the apparatus and method described herein may not be limited to the lung and may be used for tissue resection and lesion removal in other parts of the body. The invention is not limited to the specific configurations described and illustrated, but should be configured to be consistent with all modifications that may be within the scope of the appended claims.
Claims
Claim 1 A system comprising: a sealing device (200) configured to be positioned adjacent to a cored cavity at a target location, wherein the sealing device (200) comprises a portion configured to seal at least a portion of the cored cavity adjacent to a portion of the target location; and an anchor device, wherein the distal end of the anchor device is configured to be anchored to the target location; wherein the sealing device comprises a lumen configured to deliver a filler (204) to the cored cavity after the sealing device (200) has sealed at least a portion of the cored cavity, wherein the filler comprises autologous blood configured to coagulate after a predetermined period, wherein the sealing device is configured to be held in place through the anchor device for the predetermined period to allow the autologous blood to coagulate at the target location, and wherein the sealing device is configured to be spaced apart from the target location after the predetermined period. Claim 2 A system according to claim 1, wherein the sealing device comprises: a balloon catheter configured to extend an inflatable balloon into the cored cavity; and a source of fluid configured to fluidly communicate with the inflatable balloon and fill the inflatable balloon with fluid to inflate the inflatable balloon to a controlled radius. Claim 3 A system according to paragraph 2, wherein the cored cavity is formed in the lung, and the balloon catheter moves up and down the lung while maintaining contact with the lung so that the filler remains in the cored position. Claim 4 A system according to paragraph 2, wherein the controlled radius of the inflatable balloon is at least the same as the measurable radius of the cored cavity. Claim 5 A system according to paragraph 2, wherein the expandable balloon is suitable for expansion by a fluid having a temperature sufficient to cut off at least a portion of the wall of the cored cavity. Claim 6 A system according to paragraph 2, wherein a bio-adhesive is placed on the surface of the expandable balloon and, when the expandable balloon is expanded, the bio-adhesive contacts the wall of the cored cavity. Claim 7 A system according to paragraph 2, wherein the inflatable balloon is configured to transmit RF energy to at least a portion of the wall of the cored cavity. Claim 8 A system in which, in paragraph 2, the inflatable balloon is further configured to be deflated and removed after the predetermined period. Claim 9 A system according to paragraph 2, wherein the balloon catheter is configured to be inserted into the cored position over the anchor. Claim 10 A system according to claim 9, wherein the balloon catheter and the anchor are configured to be removed from the target location after a predetermined period. Claim 11 A system according to claim 1, wherein the sealing device is configured to seal at least a portion of the cored cavity to minimize the escape of the filler from the cored cavity. Claim 12 A system according to claim 1, further comprising a rotating probe configured to be inserted into and rotated in the cored cavity to provide radially continuous ablation on the wall and floor tissues of the cored cavity. Claim 13 A system according to claim 1, further comprising a tissue resection device configured to cut the core of the tissue from the target location to form the cored cavity. Claim 14 In claim 13, the tissue resection device comprises a first actuator operable to apply mechanical pressure to tissue by driving one or more clamping elements and a second actuator operable to cut tissue by driving cutting elements. Claim 15 delete Claim 16 delete Claim 17 delete Claim 18 delete Claim 19 delete Claim 20 delete Claim 21 delete Claim 22 delete Claim 23 delete Claim 24 delete Claim 25 delete Claim 26 delete
Citation Information
Patent Citations
Medical instrument
JP2014030555A
Tissue resection apparatus
JP2020018853A
Minimally invasive method and device for targeted tissue ablation
JP2020506772A
Modification of airways by application of energy
US20030233099A1
Selective lung tissue ablation
US20070043350A1
